General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises P3 Health Partners in US$2.3 Billion Merger with Foresight Acquisition Corp.

May 25, 2021
A corporate deal team advises on the transaction that will make P3 a publicly traded company.

P3 Health Partners (P3), a patient-centered and physician-led population health management company, and Foresight Acquisition Corp. (NASDAQ: FORE) (Foresight) have entered into a definitive agreement which would result in P3 becoming a publicly listed company. Upon closing of the transaction, the combined entity will be renamed P3 Health Partners and is expected to remain listed on the Nasdaq Capital Market.

Latham & Watkins LLP represents P3 Health Partners in the transaction with a corporate deal team led by Orange County/New York partner Charles Ruck, Orange County partner Scott Shean and Boston partner Wesley Holmes, with Orange County associate Brett Urig, Boston associate Jennifer Yoon and Orange County associates Christopher Martinez, Peter Bassine and Caitlin Nguyen. Advice was also provided on tax matters by Washington, D.C. partner Andrea Ramezan-Jackson, with Washington, D.C. associate Emmanuel Kassim; on benefits and compensation matters by Los Angeles partner Michelle Carpenter and Los Angeles counsel Aryeh Zuber, with Los Angeles associate Tara McCarney.